Item 7.01 Regulation FD Disclosure.
On June 11, 2009, David M. Mulder, Chief Executive Officer of Biolase
Technology, Inc., will deliver a presentation at the 8th Annual Needham Life
Sciences Conference that will include a written communication comprised of
slides. The slides from the presentation are attached hereto as Exhibit 99.1,
and are hereby incorporated by reference.
A copy of the slides will be available for viewing and download at
http://www.biolase.com/investors for a period of 30 days.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Presentation material from the 8th Annual Needham Life Sciences
Conference, dated June 11, 2009.
Add
BLTI to Portfolio
Set Alert
Email to a
Friend